Yilong Cui Selected Research

15- deoxy- (16- m- tolyl)- 17,18,19,20- tetranorisocarbacyclin methylester

1/2002

Specific ligand for a central type prostacyclin receptor attenuates neuronal damage in a rat model of focal cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yilong Cui Research Topics

Disease

4	Body Weight (Weight, Body) 07/2022 - 10/2021
3	Bone Diseases (Bone Disease) 07/2022 - 09/2021
3	Pain (Aches) 01/2022 - 05/2002
2	Neuralgia (Stump Neuralgia) 01/2022 - 01/2018
2	Fatigue 01/2020 - 05/2016
2	Neurogenic Inflammation 10/2014 - 11/2009
2	Tics (Tic) 05/2012 - 11/2010
2	Brain Ischemia (Cerebral Ischemia) 11/2006 - 01/2002
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2006 - 01/2002
1	Kashin-Beck Disease 07/2022
1	Neuroinflammatory Diseases 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Epilepsy (Aura) 01/2022
1	Fibromyalgia (Fibrositis) 01/2022
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022
1	Inflammation (Inflammations) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Mental Fatigue 05/2016
1	Nausea 05/2016
1	Osteoporosis 05/2016
1	Vomiting 05/2016
1	Hypercholesterolemia 04/2014
1	Migraine Disorders (Migraine) 11/2009
1	Infarction (Infarctions) 11/2006
1	Stroke (Strokes) 01/2002
1	Ischemia 01/2002

Drug/Important Bio-Agent (IBA)

3	Aluminum ChlorideIBA 01/2022 - 10/2021
3	LigandsIBA 11/2009 - 01/2002
2	Drinking WaterIBA 01/2022 - 10/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	AluminumIBA 11/2021 - 09/2021
2	Biological ProductsIBA 05/2016 - 05/2002
2	Blood Proteins (Serum Proteins)IBA 10/2014 - 11/2009
2	AcidsIBA 05/2012 - 11/2010
2	EstersIBA 05/2012 - 11/2010
2	Epoprostenol ReceptorsIBA 11/2006 - 01/2002
2	Neuroprotective AgentsIBA 11/2006 - 01/2002
1	T-2 Toxin (T 2 Toxin)IBA 07/2022
1	PK 11195 (PK11195)IBA 01/2022
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Kainic Acid (Kainate)IBA 01/2022
1	Lysophosphatidic Acid ReceptorsIBA 01/2022
1	MetalsIBA 11/2021
1	Environmental Pollutants (Pollutants, Environmental)IBA 09/2021
1	PlatinumIBA 01/2021
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2021
1	HydrogenIBA 01/2021
1	Hydroxyl RadicalIBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	Naloxone (Narcan)FDA LinkGeneric 01/2018
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2018
1	Opioid Receptors (Opioid Receptor)IBA 01/2018
1	AntiemeticsIBA 05/2016
1	Teriparatide (Parathar)FDA Link 05/2016
1	Peptides (Polypeptides)IBA 10/2014
1	OligodeoxyribonucleotidesIBA 04/2014
1	Pharmaceutical PreparationsIBA 04/2014
1	Nucleic AcidsIBA 04/2014
1	Proprotein Convertase 9IBA 04/2014
1	CholesterolIBA 04/2014
1	16- tolyl- 17,18,19,20- tetranorisocarbacyclinIBA 05/2012
1	Multidrug Resistance-Associated Protein 2IBA 11/2010
1	GABA-A Receptors (GABA(A) Receptor)IBA 11/2009
1	Oxygen (Dioxygen)IBA 11/2006
1	15- deoxy- (16- m- tolyl)- 17,18,19,20- tetranorisocarbacyclin methylesterIBA 01/2002
1	Iloprost (Ventavis)FDA Link 01/2002
1	Halothane (Fluothane)FDA Link 01/2002

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2014
1	Subcutaneous Injections 01/2022
1	Electrodes (Electrode) 01/2021
1	Analgesia 01/2018
1	Intravenous Injections 11/2010
1	Lasers (Laser) 05/2002
1	Anesthesia 01/2002